Advantage Alpha Capital Partners’s Gyre Therapeutics GYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-13,663	Closed	-$105K	–	143
2025 Q1	$105K	Buy	13,663 +4,790	+54%	+$37K	0.03%	146
2024 Q4	$107K	Sell	8,873 -17,761	-67%	-$215K	0.03%	148
2024 Q3	$334K	Buy	+26,634	New	+$334K	0.08%	156